Press "Enter" to skip to content

Novartis migraine drug not cost effective – U.K. price watchdog

It marks the second time within months the U.K. agency has rejected reimbursement for a key medicine from the Swiss drugmaker.

Original source: https://health.economictimes.indiatimes.com/news/pharma/novartis-migraine-drug-not-cost-effective-u-k-price-watchdog/67472618?utm_source=RSS&utm_medium=ETRSS

Also Read:   Hospital staff errors with gowns and gloves spread bacteria